216 related articles for article (PubMed ID: 22044243)
1. CD40 and tumour necrosis factor-α co-operate to up-regulate inducuble nitric oxide synthase expression in macrophages.
Portillo JA; Feliciano LM; Okenka G; Heinzel F; Subauste MC; Subauste CS
Immunology; 2012 Feb; 135(2):140-50. PubMed ID: 22044243
[TBL] [Abstract][Full Text] [Related]
2. Macrophage-dependent nitric oxide expression regulates tumor cell detachment and metastasis after IL-2/anti-CD40 immunotherapy.
Weiss JM; Ridnour LA; Back T; Hussain SP; He P; Maciag AE; Keefer LK; Murphy WJ; Harris CC; Wink DA; Wiltrout RH
J Exp Med; 2010 Oct; 207(11):2455-67. PubMed ID: 20921282
[TBL] [Abstract][Full Text] [Related]
3. Ligation of CD40 stimulates the induction of nitric-oxide synthase in microglial cells.
Jana M; Liu X; Koka S; Ghosh S; Petro TM; Pahan K
J Biol Chem; 2001 Nov; 276(48):44527-33. PubMed ID: 11551948
[TBL] [Abstract][Full Text] [Related]
4. The protein kinase double-stranded RNA-dependent (PKR) enhances protection against disease cause by a non-viral pathogen.
Ogolla PS; Portillo JA; White CL; Patel K; Lamb B; Sen GC; Subauste CS
PLoS Pathog; 2013; 9(8):e1003557. PubMed ID: 23990781
[TBL] [Abstract][Full Text] [Related]
5. CD40 signaling in macrophages induces activity against an intracellular pathogen independently of gamma interferon and reactive nitrogen intermediates.
Andrade RM; Portillo JA; Wessendarp M; Subauste CS
Infect Immun; 2005 May; 73(5):3115-23. PubMed ID: 15845519
[TBL] [Abstract][Full Text] [Related]
6. Both the Fas ligand and inducible nitric oxide synthase are needed for control of parasite replication within lesions in mice infected with Leishmania major whereas the contribution of tumor necrosis factor is minimal.
Chakour R; Guler R; Bugnon M; Allenbach C; Garcia I; Mauël J; Louis J; Tacchini-Cottier F
Infect Immun; 2003 Sep; 71(9):5287-95. PubMed ID: 12933876
[TBL] [Abstract][Full Text] [Related]
7. TNF-alpha mediates the induction of nitric oxide synthase in macrophages but not in neutrophils in experimental cutaneous leishmaniasis.
Fonseca SG; Romão PR; Figueiredo F; Morais RH; Lima HC; Ferreira SH; Cunha FQ
Eur J Immunol; 2003 Aug; 33(8):2297-306. PubMed ID: 12884305
[TBL] [Abstract][Full Text] [Related]
8. T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells.
Marigo I; Zilio S; Desantis G; Mlecnik B; Agnellini AHR; Ugel S; Sasso MS; Qualls JE; Kratochvill F; Zanovello P; Molon B; Ries CH; Runza V; Hoves S; Bilocq AM; Bindea G; Mazza EMC; Bicciato S; Galon J; Murray PJ; Bronte V
Cancer Cell; 2016 Sep; 30(3):377-390. PubMed ID: 27622331
[TBL] [Abstract][Full Text] [Related]
9. Tumoristatic effects of anti-CD40 mAb-activated macrophages involve nitric oxide and tumour necrosis factor-alpha.
Lum HD; Buhtoiarov IN; Schmidt BE; Berke G; Paulnock DM; Sondel PM; Rakhmilevich AL
Immunology; 2006 Jun; 118(2):261-70. PubMed ID: 16771862
[TBL] [Abstract][Full Text] [Related]
10. Regulation of type 2 nitric oxide synthase by type 1 interferons in macrophages infected with Leishmania major.
Mattner J; Schindler H; Diefenbach A; Röllinghoff M; Gresser I; Bogdan C
Eur J Immunol; 2000 Aug; 30(8):2257-67. PubMed ID: 10940917
[TBL] [Abstract][Full Text] [Related]
11. Regulation of tumor necrosis factor-alpha expression by CD40 ligation in BV-2 microglial cells.
Jana M; Dasgupta S; Liu X; Pahan K
J Neurochem; 2002 Jan; 80(1):197-206. PubMed ID: 11796758
[TBL] [Abstract][Full Text] [Related]
12. Early myeloid cells are high producers of nitric oxide upon CD40 plus IFN-gamma stimulation through a mechanism dependent on endogenous TNF-alpha and IL-1alpha.
Angulo I; Rullas J; Campillo JA; Obregón E; Heath A; Howard M; Muñoz-Fernández MA; Subiza JL
Eur J Immunol; 2000 May; 30(5):1263-71. PubMed ID: 10820371
[TBL] [Abstract][Full Text] [Related]
13. Migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-alpha.
Jüttner S; Bernhagen J; Metz CN; Röllinghoff M; Bucala R; Gessner A
J Immunol; 1998 Sep; 161(5):2383-90. PubMed ID: 9725234
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of localized and systemic immune responses in cutaneous leishmaniasis caused by Leishmania tropica: interleukin-8, monocyte chemotactic protein-1 and nitric oxide are major regulatory factors.
Kumar R; Bumb RA; Salotra P
Immunology; 2010 Jun; 130(2):193-201. PubMed ID: 20102417
[TBL] [Abstract][Full Text] [Related]
15. Cholesterol depletion associated with Leishmania major infection alters macrophage CD40 signalosome composition and effector function.
Rub A; Dey R; Jadhav M; Kamat R; Chakkaramakkil S; Majumdar S; Mukhopadhyaya R; Saha B
Nat Immunol; 2009 Mar; 10(3):273-80. PubMed ID: 19198591
[TBL] [Abstract][Full Text] [Related]
16. iNOS-producing inflammatory dendritic cells constitute the major infected cell type during the chronic Leishmania major infection phase of C57BL/6 resistant mice.
De Trez C; Magez S; Akira S; Ryffel B; Carlier Y; Muraille E
PLoS Pathog; 2009 Jun; 5(6):e1000494. PubMed ID: 19557162
[TBL] [Abstract][Full Text] [Related]
17. TNF-Mediated Restriction of Arginase 1 Expression in Myeloid Cells Triggers Type 2 NO Synthase Activity at the Site of Infection.
Schleicher U; Paduch K; Debus A; Obermeyer S; König T; Kling JC; Ribechini E; Dudziak D; Mougiakakos D; Murray PJ; Ostuni R; Körner H; Bogdan C
Cell Rep; 2016 May; 15(5):1062-1075. PubMed ID: 27117406
[TBL] [Abstract][Full Text] [Related]
18. alpha-MSH inhibits induction of C/EBPbeta-DNA binding activity and NOS2 gene transcription in macrophages.
Gupta AK; Diaz RA; Higham S; Kone BC
Kidney Int; 2000 Jun; 57(6):2239-48. PubMed ID: 10844594
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of nitric oxide in LPS-stimulated macrophages of young and senescent mice by δ-tocotrienol and quercetin.
Qureshi AA; Tan X; Reis JC; Badr MZ; Papasian CJ; Morrison DC; Qureshi N
Lipids Health Dis; 2011 Dec; 10():239. PubMed ID: 22185406
[TBL] [Abstract][Full Text] [Related]
20. Control of Leishmania major infection in mice lacking TNF receptors.
Nashleanas M; Kanaly S; Scott P
J Immunol; 1998 Jun; 160(11):5506-13. PubMed ID: 9605154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
